Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006 by Long, G.V, Blank, C, Ribas, A, Mortier, L, Carlino, M.S, Lotem, M, Lorigan, P, Neyns, B, Petrella, T.M, Puzanov, I, Richtig, E, O’Day, S.J, Masucci, G, Lebbe, C, Steven, N, Lutzky, J, Hille, D, Ebbinghaus, S, Ibrahim, N, McNeil, C

Get full text

23LBA BEAM: A randomized phase II study evaluating the activity of BEvacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated Advanced Melano... by O'Day, S.J, Kim, K.B, Sosman, J.A, Peterson, A.C, Feng, S, Minor, D.R, Fruehauf, J.P, Linette, G.P, Markovic, S.N, Carson, W.E

Get full text

1141 - Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006 by Long, G.V., Blank, C., Ribas, A., Mortier, L., Carlino, M.S., Lotem, M., Lorigan, P., Neyns, B., Petrella, T.M., Puzanov, I., Richtig, E., O’Day, S.J., Masucci, G., Lebbe, C., Steven, N., Lutzky, J., Hille, D., Ebbinghaus, S., Ibrahim, N., McNeil, C.

Get full text

Safety profile of histamine dihydrochloride administered with interleukin-2 in patients with advanced metastatic malignant melanoma by O'Day, S.J., Glaspy, J., Whitman, E., Kass, C.L., Gehlsen, K.R., Agarwala, S.S.

Get full text

RAF Inhibitor Dabrafenib (GSK2118436) is Active in Melanoma Brain Metastases, Multiple BRAF Genotypes and Diverse Cancers by Falchook, G.S., Long, G.V., Kurzrock, R., Kim, K.B., Arkenau, H.T., Brown, M.P., Hamid, O., Infante, J.R., Millward, M., Pavlick, A., O’Day, S.J., Blackman, S.C., Curtis, C.M., Lebowitz, P., Ma, B., Ouellet, D., Kefford, R.F.

Get full text

Comparative efficacy of different CIDR protocols for the treatment of postpartum anestrous in Iraqi buffaloes by Azawi, O.I, Ali, M.D, Oday, S.A, Salih, A, Al-Hadad, A.S, Mouayad, S.J, AbdulHussien, A.S

Get full text